Hair loss risk goes up on GLP-1 drugs, BMJ study finds
The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients using other diabetes drugs such as SGLT-2 and DPP-4.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
